von Schilling C - Search Results

1

Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.

Langer R, Geissinger E, Rüdiger T, von Schilling C, Ott G, Mandl-Weber S, Quintanilla-Martinez L, Fend F. Langer R, et al. Among authors: von schilling c. Am J Surg Pathol. 2010 Sep;34(9):1382-7. doi: 10.1097/PAS.0b013e3181ec577a. Am J Surg Pathol. 2010. PMID: 20739840

2

Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis.

Kremer M, Quintanilla-Martínez L, Nährig J, von Schilling C, Fend F. Kremer M, et al. Among authors: von schilling c. Virchows Arch. 2005 Dec;447(6):920-37. doi: 10.1007/s00428-005-0070-8. Epub 2005 Oct 18. Virchows Arch. 2005. PMID: 16231177 Review.

3

Monocytoid B-cell lymphoma: morphological variants and relationship to low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue.

Nizze H, Cogliatti SB, von Schilling C, Feller AC, Lennert K. Nizze H, et al. Among authors: von schilling c. Histopathology. 1991 May;18(5):403-14. doi: 10.1111/j.1365-2559.1991.tb00870.x. Histopathology. 1991. PMID: 1885166

4

Splenic marginal zone lymphocytes and related cells in the lymph node: a morphologic and immunohistochemical study.

van Krieken JH, von Schilling C, Kluin PM, Lennert K. van Krieken JH, et al. Among authors: von schilling c. Hum Pathol. 1989 Apr;20(4):320-5. doi: 10.1016/0046-8177(89)90040-3. Hum Pathol. 1989. PMID: 2703226

5

Myeloablative anti-CD20 radioimmunotherapy +/- high-dose chemotherapy followed by autologous stem cell support for relapsed/refractory B-cell lymphoma results in excellent long-term survival.

Wagner JY, Schwarz K, Schreiber S, Schmidt B, Wester HJ, Schwaiger M, Peschel C, von Schilling C, Scheidhauer K, Keller U. Wagner JY, et al. Among authors: von schilling c. Oncotarget. 2013 Jun;4(6):899-910. doi: 10.18632/oncotarget.1037. Oncotarget. 2013. PMID: 23765188 Free PMC article. Clinical Trial.

6

Immunotherapy with anti-CD20 compounds.

von Schilling C. von Schilling C. Semin Cancer Biol. 2003 Jun;13(3):211-22. doi: 10.1016/s1044-579x(03)00018-x. Semin Cancer Biol. 2003. PMID: 12959352 Review.

7

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

Gruss HJ, Pinto A, Gloghini A, Wehnes E, Wright B, Boiani N, Aldinucci D, Gattei V, Zagonel V, Smith CA, Kadin ME, von Schilling C, Goodwin RG, Herrmann F, Carbone A. Gruss HJ, et al. Among authors: von schilling c. Am J Pathol. 1996 Aug;149(2):469-81. Am J Pathol. 1996. PMID: 8701986 Free PMC article.

8

Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? Against.

von Schilling C. von Schilling C. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1254-6. doi: 10.1007/s00259-002-0929-8. Eur J Nucl Med Mol Imaging. 2002. PMID: 12418478 No abstract available.

9

Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts.

Baumgartner B, Weber M, Quirling M, Fischer C, Page S, Adam M, Von Schilling C, Waterhouse C, Schmid C, Neumeier D, Brand K. Baumgartner B, et al. Among authors: von schilling c. Leukemia. 2002 Oct;16(10):2062-71. doi: 10.1038/sj.leu.2402641. Leukemia. 2002. PMID: 12357358

10

Pitfalls in imaging Hodgkin's disease with computed tomography and positron emission tomography using fluorine-18-fluorodeoxyglucose.

Sandherr M, von Schilling C, Link T, Stock K, von Bubnoff N, Peschel C, Avril N. Sandherr M, et al. Among authors: von schilling c, von bubnoff n. Ann Oncol. 2001 May;12(5):719-22. doi: 10.1023/a:1011136324038. Ann Oncol. 2001. PMID: 11432634 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page